Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

NCT01798056 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster
Herpes Zoster Vaccine

Interventions

BIOLOGICAL: GSK 1437173A
DRUG: Placebo

Sponsor

GlaxoSmithKline